3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pleural Effusion, Malignant
3
Immunoglobulin Light-chain Amyloidosis
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Mycosis Fungoides
2
Lymphoma, Non-Hodgkin
2
Amyloidosis
2
Waldenstrom Macroglobulinemia
1
Urologic Neoplasms
1
Tuberous Sclerosis
1
Tissue Adhesions
1
Skin Toxicity
1
Sezary Syndrome
1
Ras-wildtype Colorectal Cancer
1
Polyps
1
Polycystic Ovary Syndrome
1
Pleural Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neurofibromatosis 2
1
Neoplasms, Second Primary
1
Myoma
1
Menstruation Disturbances
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Interventions
Metformin
139
Clomiphene
44
Letrozole
36
Inositol
28
Folic Acid
17
Exercise
17
Progesterone
16
Ethinyl Estradiol
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Chorionic Gonadotropin
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
8
Diet
8
Cholecalciferol
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Menotropins
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polycystic Ovary Syndrome
×
Doxycycline
×
Clear all
NCT01788215
2016-01-13
MI-PCOS
University of Rochester
Phase 3
Completed
10 enrolled
14 charts